Testing a weight loss injection for people with overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests an injectable medication called Olatorepatide to help people with overweight or obesity lose weight. It is only for people without diabetes who meet specific body mass index (BMI) requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have a BMI of 30 or higher (or a BMI of 27 or higher with a weight-related health condition like high blood pressure or sleep apnea).
- You do not have type 1 or type 2 diabetes.
- Your weight has not changed by more than 11 pounds in the last 3 months.
- You have not had weight-loss surgery.
- You have not had pancreatitis or gallbladder problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.